Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders-Reference-Cited by-同舟云学术

Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders

Published:2004-10 Issue:5 Volume:25 Page:472-492
ISSN:0197-2456
Container-title:Controlled Clinical Trials
language:en
Short-container-title:Controlled Clinical Trials

Author:

Lee William M.,Dienstag Jules L.,Lindsay Karen L.,Lok Anna S.,Bonkovsky Herbert L.,Shiffman Mitchell L.,Everson Gregory T.,Di Bisceglie Adrian M.,Morgan Timothy R.,Ghany Marc G.,Morishima Chihiro,Wright Elizabeth C.,Everhart James E.

Publisher

Elsevier BV

Subject

Pharmacology

Reference32 articles.

1. The burden of hepatitis C in the United States;Kim;Hepatology,2002

2. Course and outcome of hepatitis C;Hoofnagle;Hepatology,2002

3. Hepatocellular carcinoma and hepatitis C in the United States;El-Serag;Hepatology,2002

4. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy;Marcellin;Ann. Intern. Med.,1997

5. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial;Manns;Lancet,2001

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver function and portal‐systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices;Alimentary Pharmacology & Therapeutics;2024-05-22

2. Advances in noninvasive measurement of liver function and physiology: The HepQuant DuO test;Basic & Clinical Pharmacology & Toxicology;2024-01-15

3. Effect of dietary branched chain amino acids on liver related mortality: Results from a large cohort of North American patients with advanced HCV infection;PLOS ONE;2023-04-25

4. Minimum platelet count threshold before invasive procedures in cirrhosis: Evolution of the guidelines;World Journal of Gastrointestinal Surgery;2023-02-27

5. Nanomedicine based approaches for combating viral infections;Journal of Controlled Release;2021-10